Roche Holding AG
Closed
SectorHealthcare
325.6 0.74
Overview
Share price change
24h
Min
325.4
Max
326.6
Income | 1.8B 5.5B |
|---|---|
Sales | 15B 31B |
P/E Sector Avg | 20.461 67.147 |
Dividend yield | 2.97 |
Profit margin | 17.892 |
Employees | 103,249 |
EBITDA | 5.1B 12B |
Dividend yield Sector Avg | 2.97% 2.36% |
|---|
Market Cap | -28B 261B |
|---|---|
Previous open | 324.86 |
Previous close | 325.6 |
News Sentiment
By Acuity
14%
86%
24 / 347 Ranking in Healthcare
Roche Holding AG Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Roche Holding AG Forecast
Sentiment
By Acuity
24 / 347 Ranking in Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
